IP Library Granted Patent US 7,009,047
Granted Patent B2
US 7,009,047 · App. 10/389,872 · Granted Mar 7, 2006

Ethane-1,2-diaminium bis[(2R)-2-bromo-3-phenylpropanoate], processes for its preparation and its use

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,009,047
App. No.
10/389,872
Granted
Mar 7, 2006
Kind
B2
Abstract

The present invention relates to ethane-1,2-diaminium bis[(2R)-2-bromo-3-phenyl-propanoate], the preparation of ethane-1,2-diaminium bis[(2R)-2-bromo-3-phenyl-propanoate] from (2R)-2-bromo-3-phenylpropionic acid and ethylenediamine in 2-propanol, and the use of ethane-1,2-diaminium bis[(2R)-2-bromo-3-phenyl-propanoate] for the preparation of ACE/NEP inhibitors.

Claims (40)

1. A salt which is Ethane-1,2-diaminium bis[(2R)-2-bromo-3-phenylpropanoate].

2. The salt as claimed in claim 1 having a chemical purity of greater than or equal to 98%.

3. The salt as claimed in claim 1 having an enantiomeric purity of greater than 83.4% ee.

4. The salt as claimed in claim 3 having an enantiomeric purity of greater than or equal to 95% ee.

5. The salt as claimed in claim 3 having an enantiomeric purity of greater than or equal to 98% ee.

6. A process for the preparation of a crystalline salt form of the salt, ethane-1,2-diaminium bis[(2R)-2-bromo-3-phenylpropanoate], which comprises

a) mixing (2R)-2-bromo-3-phenylpropionic acid, ethylenediamine and 2-propanol, whereupon the salt, ethane-1,2-diaminium bis[(2R)-2-bromo-3-phenylpropanoate], crystallizes out from the solution, and

b) isolating the crystallized salt, ethane-1,2-diaminium bis[(2R)-2-bromo-3-phenylpropanoate].

7. The process as claimed in claim 6 , wherein the crystalline form of the salt, ethane-1,2-diaminium bis[(2R)-2-bromo-3-phenylpropanoate], has a higher chemical purity than the starting material (2R)-2-bromo-3-phenylpropionic acid.

8. The process as claimed in claim 7 , the chemical purity of the crystalline form of the salt, ethane-1,2-diaminium bis[(2R)-2-bromo-3-phenylpropanoate], is greater than 92.5 %.

9. The process as claimed in claim 7 , wherein the chemical purity of the crystalline form of the salt, ethane-1,2-di-aminium bis[(2R)-2-bromo-3-phenylpropanoate]is at least 98 %.

10. The process as claimed in claim 6 , wherein the crystalline form of the salt, ethane-1,2-di-aminium bis[(2R)-2-bromo-3-phenylpropanoate], is isolated in process step b) by filtering off, or filtering off with suction, the crystalline salt, washing the crystalline salt with 2-propanol and drying the crystalline salt.

11. A process for the preparation of a compound of the formula (I)

wherein

R 1 is H, C 1 –C 4 -alkyl or an aryl-Y— group, where Y is a single bond or C 1 –C 4 -alkyl,

R 3 is H, acetyl, or benzoyl, and

Z is (CH 2 ) n , —O—, S, NR 6 or N—C(O)R 7 , where n is an integer 0 or 1, R 6 is H, C 1 –C 4 -alkyl or an aryl-Y— group, and R 7 is CF 3 , C 1 –C 10 -alkyl or an aryl-Y— group,

which comprises

a) synthesizing (2R)-2-bromo-3-phenylpropionic acid from ethane-1,2-di-aminium bis[(2R)-2-bromo-3-phenylpropanoate] by addition of an acid; then

either

b) reacting (2R)-2-bromo-3-phenylpropionic acid with a compound of the formula (II)

 to form a 2-bromo-3-phenylpropionamide compound; then

c) reacting the 2-bromo-3-phenylpropionamide compound with a thio reactant to give a compound of the formula (I); and

d) when R 3 of formula (I) is acetyl or benzoyl, then optionally converting a compound of formula (I) to a compound of formula (I), wherein R 3 is H;

or

e) reacting (2R)-2-bromo-3-phenylpropionic acid with a thio reactant to give (S)-2-(R 3 -thio)-3-phenylpropionic acid, wherein R 3 is acetyl or benzoyl; then

f) reacting (S)-2-(R 3 -thio)-3-phenylpropionic acid with a compound of the formula (II) to give a compound of the formula (I); and

g) when R 3 of formula (I) is acetyl or benzoyl, then optionally converting a compound of formula (I) to a compound of formula (I) wherein R 3 is H.

12. The process as claimed in claim 11 wherein the compound of the formula (I) is described by a compound of the formula (Ia)

13. The process as claimed in claim 11 , further comprising isolating (2R)-2-bromo-3-phenylpropionic acid in step (a).

14. The process as claimed in claim 11 wherein the thio reactant is thioacetate.

15. The process as claimed in claim 11 wherein R 3 is acetyl.

16. A process for the preparation of the compound of the formula (III)

which comprises

a) synthesizing (2R)-2-bromo-3-phenylpropionic acid from ethane-1,2-diaminium bis[(2R)-2-bromo-3-phenylpropanoate] by addition of an acid; then

b) reacting (2R)-2-bromo-3-phenylpropionic acid with thioacetate to give (S)-2-(acetylthio)-3-phenylpropionic acid; and

c) reacting (acetylthio)-3-phenylpropionic acid with a compound of the formula (IV)

 to form a compound of formula (V)

d) converting a compound of formula (V) to a compound of formula (Ill).

17. The process as claimed in claim 16 , further comprising isolating (2R)-2-bromo-3-phenylpropionic acid in step (a).

Assignments (4)
CORRECTIVE ASSIGNMENT TO CORRECT THE APPLICATION NO. 16/990,698 PREVIOUSLY RECORDED ON REEL 058294 FRAME 0010. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Apr 21, 2022
From: TRU OPTIK DATA CORP.; NEUSTAR INFORMATION SERVICES, INC.; NEUSTAR DATA SERVICES, INC.; TRUSTID, INC.; NEUSTAR, INC.; NEUSTAR IP INTELLIGENCE, INC.; MARKETSHARE PARTNERS, LLC; SONTIQ, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH
Reel/Frame 059846/0157 →
GRANT OF SECURITY INTEREST IN PATENT RIGHTS Recorded Dec 1, 2021
From: TRU OPTIK DATA CORP.; NEUSTAR INFORMATION SERVICES, INC.; NEUSTAR DATA SERVICES, INC.; TRUSTID, INC.; NEUSTAR, INC.; NEUSTAR IP INTELLIGENCE, INC.; MARKETSHARE PARTNERS, LLC; SONTIQ, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH
Reel/Frame 058294/0010 →
GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Dec 1, 2021
From: EBUREAU, LLC; IOVATION, INC.; SIGNAL DIGITAL, INC.; TRANS UNION LLC; TRANSUNION HEALTHCARE, INC.; TRANSUNION INTERACTIVE, INC.; TRANSUNION RENTAL SCREENING SOLUTIONS, INC.; TRANSUNION TELEDATA LLC; AGGREGATE KNOWLEDGE, LLC; TRU OPTIK DATA CORP.; NEUSTAR INFORMATION SERVICES, INC.; TRUSTID, INC.; NEUSTAR, INC.; NEUSTAR IP INTELLIGENCE, INC.; MARKETSHARE PARTNERS, LLC; SONTIQ, INC.
To: JPMORGAN CHASE BANK, N.A
Reel/Frame 058294/0161 →
CHANGE OF NAME Recorded Nov 2, 2005
From: AVENTIS PHARMA DEUTSCHLAND GMBH
To: SANOFI-AVENTIS DEUTSCHLAND GMBH
Reel/Frame 016720/0092 →